Cite
MLA Citation
Johannes Weller et al.. “QOLP-20. QUALITY OF LIFE IN THE PHASE III CeTeG/NOA-09 TRIAL RANDOMIZING CCNU/TEMOZOLOMIDE (TMZ) COMBINATION THERAPY VS. STANDARD TMZ THERAPY FOR NEWLY DIAGNOSED MGMT-METHYLATED GLIOBLASTOMA.” Neuro-oncology, vol. 20, n.d., pp. vi218–vi219. http://access.bl.uk/ark:/81055/vdc_100095323704.0x000017